ABBV-744 AS A POTENTIAL THERAPEUTIC OPTION FOR AGGRESSIVE CANCERS SECRETS

Further studies in progress recommend that ARV-825 might also be effective in enhancing the reaction to estrogen deprivation (aromatase inhibition), another element of standard of care in ER+ breast cancer.- "Our study exposed the vital part in the KLF16/MYC regulatory axis in modulating tumor progress and chemotherapy sensitivity in BLCA, suggesti